Keeping Pace with Real-World Evidence: Evolving Software Regulations and the Growing Application of Artificial Intelligence
- IQVIA
- Digital Health
Whether you are in development or ready for commercialization, real-world data solutions can be used to help navigate complex regulatory pathways and decision-making. Download this white paper from IQVIA – an associate member of AdvaMed® – to explore the increasing spotlight on the use of real world evidence, what regulators are looking for, and how AI-powered applications are rising in the field of digital health from code to commercialization.
Related Reading
Blog / Artificial Intelligence (AI) / Diagnostics / Digital Health / Health Access
The Insight Series: AI & Digital Health
April 24, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. Our latest edition features Carlos Nunez, Chief Medical Officer at Resmed.
News / Digital Health / Health Access
Gravitas Medical Launches Multicenter NICU Study of Next-Generation Smart Feeding Tube System
April 23, 2026
BERKELEY, Calif., April 21, 2026 — Gravitas Medical, Inc., a developer of advanced enteral feeding technologies, today announced the initiation of a prospective, multicenter clinical study evaluating its next-generation (Gen 2) smart feeding tube system in neonatal and infant patients. The Gravitas Entarik™ Feeding Tube System is FDA-cleared and has received Breakthrough Device Designation from the U.S. Food and Drug Administration. The study is being conducted at three leading institutions, including HCA Memorial Health Savannah.
Event / Digital Health / Regulatory Affairs
AdvaMed® Cybersecurity Summit
November 10, 2026
Join cyber experts for the 2026 Cybersecurity Summit to address the latest industry issues and FDA requirements.
Blog / Artificial Intelligence (AI) / Diagnostics / Digital Health / Health Access
The Insight Series: AI & Digital Health
March 30, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. Our latest edition features Julia Strandberg, Executive Vice President, Chief Business Leader, Connected Care at Philips.
Event / Digital Health
Expanding Service Margins While Protecting Clinical Availability
March 26, 2026
11:30 AM – 12:30 PM
Join Genpact as they help Medtech Service leaders tackle the margin challenge by transitioning to a Predictive Triage & Guaranteed Uptime model.
Resource / Digital Health / Government & Legislative Affairs
AdvaMed® 2025 Membership Has Its Privileges: Advocacy Wins for Medtech Members
March 3, 2026
AdvaMed® 2025 Membership Has Its Privileges highlights major legislative and regulatory wins delivering millions in savings and new revenue for members.
Resource / Artificial Intelligence (AI) / Coverage & Payment / Digital Health / Regulatory Affairs
AdvaMed® Comment Letter to ASTP/ONC: Accelerating AI Adoption in Clinical Care
February 24, 2026
AdvaMed’s® Comment Letter to ASTP/ONC, outlines concrete policy reforms across FDA oversight, CMS payment pathways, and HIPAA data-sharing rules to accelerate patient access to AI-enabled medical technologies. As AI-enabled medical devices transform patient care, outdated regulatory, coverage, and privacy frameworks are slowing the pace of adoption.
News / Diabetes / Digital Health
Dexcom’s Jake Leach Named Chair of AdvaMed’s Diabetes Sector
February 23, 2026
WASHINGTON—AdvaMed, the MedTech Association®, today announced that Jacob “Jake” Leach, President and Chief Executive Officer at Dexcom, will serve as the next chair of theAdvaMed® Diabetes Sector, succeeding Chris Scoggins, Executive Vice President of Diabetes Care at Abbott. TheAdvaMed® Diabetes Sector represents the world’s leading companies producing technology across the spectrum of diabetes care.